Marizyme
Davenport, US · Nevada corporation
Find your way into Marizyme
Sign up to see every warm intro you have to Marizyme
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Marizyme team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
TB
Terry BrostowinNamed on SEC filing
JS
James SapirsteinNamed on SEC filing
ND
Nicholas DeVitoNamed on SEC filing
Funding
SEC filings, press & company announcements$9.2M disclosed across 5 of 6 rounds · 2018–2023
- Undisclosed amountPrivate PlacementSep 2020Source ↗
▶$1MraisedMay 2023 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedMay 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William HearlDirector
- Michael StewartDirector
- Steven BrooksExecutive Officer
- David BarthelExecutive Officer, Director
- Vithalbhai DhadukExecutive Officer, Director
- Nilesh PatelDirector
- Catherine PachukExecutive Officer
- Terry BrostowinDirector
- George KovalyovExecutive Officer
- Julie KampfDirector
- Harrison RossExecutive Officer
- Offering amount
- $10M
- Amount sold
- $1M
- Minimum investment
- $1K
- Sales commissions
- $800K
- Placement agents
- Univest Securities, LLC
- First sale
- May 2023
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$265.2KraisedMay 2023 · 4 investors · BiotechnologyRule 506(b)
▶$265.2KraisedMay 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven BrooksExecutive Officer
- David BarthelExecutive Officer, Director
- Vithalbhai DhadukExecutive Officer, Director
- Michael StewartDirector
- Terry BrostowinDirector
- Catherine PachukExecutive Officer
- Julie KampfDirector
- George KovalyovExecutive Officer
- William HearlDirector
- Nilesh PatelDirector
- Harrison RossExecutive Officer
- Offering amount
- $265.2K
- Amount sold
- $265.2K
- First sale
- Apr 2023
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$1.2MraisedNov 2021 · 4 investors · BiotechnologyRule 506(b)
▶$1.2MraisedNov 2021 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bradley RichmondExecutive Officer
- Vithalbhai DhadukDirector
- Steven BrooksExecutive Officer
- Catherine PachukExecutive Officer
- Julie KampfDirector
- William HearlDirector
- Terry BrostowinDirector
- Offering amount
- $10M
- Amount sold
- $1.2M
- Sales commissions
- $94K
- Placement agents
- Univest Securities, LLC
- First sale
- May 2021
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$1.2MraisedOct 2021 · 4 investors · BiotechnologyRule 506(b)
▶$1.2MraisedOct 2021 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Donald VeryExecutive Officer
- Steven BrooksExecutive Officer
- Vithalbhai DhadukDirector
- Julie KampfDirector
- Bradley RichmondExecutive Officer
- Catherine PachukExecutive Officer
- Terry BrostowinDirector
- Roger SchallerExecutive Officer
- William HearlDirector
- Amy ChandlerExecutive Officer
- Offering amount
- $10M
- Amount sold
- $1.2M
- Sales commissions
- $94K
- Placement agents
- Univest Securities, LLC
- First sale
- May 2021
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$5.6MraisedAug 2020 · 22 investors · BiotechnologyRule 506(b)
▶$5.6MraisedAug 2020 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Terry BrostowinDirector
- James SapirsteinExecutive Officer, Director
- Nicholas DeVitoExecutive Officer
- Offering amount
- $6M
- Amount sold
- $5.6M
- Placement agents
- Univest Securities, LLC
- First sale
- Sep 2018
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Marizyme raised?
- Marizyme has disclosed $9.2M raised across 5 of its 6 known rounds.
- Where is Marizyme headquartered?
- Marizyme is headquartered in Davenport, US.